Inspire Medical Systems INSP Business Segments — Cost of goods sold
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Inspire Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inspire Medical Systems's business segments — cost of goods sold.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Inspire Medical Systems's business segments — cost of goods sold?
- Inspire Medical Systems (INSP) reported business segments — cost of goods sold of $27.67M in Q1 2026.
- How has Inspire Medical Systems's business segments — cost of goods sold changed year-over-year?
- Inspire Medical Systems's business segments — cost of goods sold decreased by 9.9% year-over-year, from $30.71M to $27.67M.
- What is the long-term trend for Inspire Medical Systems's business segments — cost of goods sold?
- Over 3 years (2022 to 2025), Inspire Medical Systems's business segments — cost of goods sold has grown at a 26.3% compound annual growth rate (CAGR), from $66.12M to $133.23M.
- What does business segments — cost of goods sold mean?
- Includes the direct costs attributable to the production and delivery of the company's medical devices, such as raw materials, manufacturing labor, and overhead. Monitoring this metric is essential for evaluating production efficiency and the impact of manufacturing scale on gross margins.